Extravasation of Cytotoxic Agents: Compendium for Prevention and Management

Author:   Ines Mader ,  Birte Twisselmann ,  Patrizia R. Fürst-Weger ,  Robert M. Mader
Publisher:   Springer Verlag GmbH
Edition:   2nd ed. 2010
ISBN:  

9783709116678


Pages:   392
Publication Date:   13 December 2014
Format:   Paperback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $335.95 Quantity:  
Add to Cart

Share |

Extravasation of Cytotoxic Agents: Compendium for Prevention and Management


Add your own review!

Overview

The extravasation of cytotoxic agents can result in severe local tissue damage and medical emergencies during tumour therapy. This revised compendium is intended to help clinicians assess any situation speedily and with certainty. The general section of the book includes topics such as predisposition, prevention, type of harm, general measures in handling extravasated drugs, specific antidotes, and documentation. In the 2nd edition, the scientific information contained in the general section and relating to the actual substances has been updated. The substance specific part of the book includes detailed instructions on handling more than 50 cytotoxic drugs, to initiate targeted measures. Templates for an extravasation set, overview tables, documentation sheets, and patient information, as we as a CD-ROM are included to support clinical practice. The book is the outcome of a consensus of an interdisciplinary working group that has collected and systematically reviewed all published literature on the topic.

Full Product Details

Author:   Ines Mader ,  Birte Twisselmann ,  Patrizia R. Fürst-Weger ,  Robert M. Mader
Publisher:   Springer Verlag GmbH
Imprint:   Springer Verlag GmbH
Edition:   2nd ed. 2010
Dimensions:   Width: 15.50cm , Height: 2.10cm , Length: 23.50cm
Weight:   0.629kg
ISBN:  

9783709116678


ISBN 10:   3709116678
Pages:   392
Publication Date:   13 December 2014
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Problem outline.- Problem outline.- General part.- and definitions.- Predisposition and prevention.- Clinical practice.- Measures.- Aftercare.- Documentation.- Forming clinical working groups.- Quality control and quality assurance.- Open questions and outlook.- Substance-specific part.- Remarks on the substance-specific part.- Amsacrine.- L-Asparaginase.- Bendamustine.- Bleomycin.- Bortezomib.- Busulfan.- Carboplatin.- Carmustine.- Cisplatin.- Cladribine.- Cyclophosphamide.- Cytarabine.- Dacarbazine.- Dactinomycin.- Daunorubicin.- Daunorubicin liposomal.- Docetaxel.- Doxorubicin.- Doxorubicin liposomal, Doxorubicin pegylated liposomal.- Epirubicin.- Estramustine.- Etoposide.- Etoposide phosphate.- Fludarabine.- 5-Fluorouracil.- Fotemustine.- Gemcitabine.- Idarubicin.- Ifosfamide.- Irinotecan.- Melphalan.- Methotrexate.- Mitomycin C.- Mitoxantrone.- Nimustine.- Oxaliplatin.- Paclitaxel.- Pegaspargase.- Pemetrexed.- Pentostatin.- Raltitrexed.- Streptozocin.- Teniposide.- Thiotepa.- Topotecan.- Treosulfan.- Trimetrexate.- Vinblastine.- Vincristine.- Vindesine.- Vinorelbine.

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List